MDMA Therapy Through My FDA Lens

From Regulation to Revelation: MDMA Therapy Through My FDA Lens

Last month while reading The New York Times, I came across an article that made me pause-not as a casual reader, but as someone who once stood inside the machinery of public health.

The topic? MDMA therapy-yes, the same compound once known to most of us as Ecstasy or Molly, now being used in carefully controlled settings to treat severe trauma.

And remarkably, this is not theoretical. It is already happening in Australia.

A Regulatory First-And a Bold One

In 2023, Australia became the first nation to formally allow psychiatrists to prescribe MDMA-assisted therapy for severe Post-Traumatic Stress Disorder.

From my years at the U.S. Food and Drug Administration, I can tell you: decisions like this are never taken lightly.

They require layers of evidence, debate, skepticism, and above all, responsibility to the public.

What Australia has done is bold, but not reckless.

It is the result of years of clinical trials suggesting that, under controlled conditions, MDMA can help patients revisit trauma without being overwhelmed by it.

The Science Meets the Human Condition

We in public health often speak in terms of data-percentages, outcomes, adverse effects.

But behind every dataset is a human story.

MDMA, as researchers describe it, reduces fear and increases emotional openness. It allows patients to confront memories they have spent years avoiding.

If traditional therapy is like knocking on a locked door, MDMA therapy may, at least for some -gently open it.

That, to me, is both fascinating and humbling. 

The FDA Perspective: Why the U.S. Moves More Slowly

Here in the United States, the U.S. Food and Drug Administration has not yet approved MDMA therapy.

And I understand why. The FDA’s role is not to chase promise-it is to verify it.

Questions remain:

• Are the clinical trials sufficiently rigorous?
• Can results be replicated across diverse populations?
• What are the long-term safety implications?
• How do we prevent misuse outside controlled environments?

These are not bureaucratic hurdles. They are safeguards-hard-earned through decades of experience.

A Shift in How We View Healing

Yet, even with my regulatory instincts, I cannot ignore what this represents.

For decades, substances like MDMA were categorized solely as dangers placed firmly outside the boundaries of medicine.

Now, we are being asked to reconsider. Not recklessly. Not casually. But thoughtfully.

And perhaps that is the true story here-not just MDMA, but the evolution of medicine itself.

A Personal Reflection

Over the years through my time in public service, through witnessing national tragedies like 9/11, and through my daily discipline of writing since 2009, I have come to appreciate one simple truth:

Not all wounds are visible, and not all healing is straightforward.

We have long relied on conventional tools: medications, counseling, time.

But trauma has a way of resisting simplicity. Reading about MDMA therapy, I found myself thinking not as a regulator, but as a human being:

What if healing sometimes requires us to revisit the past, not with fear, but with compassion?

Hope, With Guardrails

Let me be clear-this is not a miracle cure. It is expensive. It is highly controlled. It is not suitable for everyone. And yes, it carries risks. 

But it also carries something equally important: Possibility.

Closing Thoughts: The Balance Between Caution and Courage

If there is one lesson I carry from my FDA years, it is this:

Progress in medicine is always a balance between caution and courage.

Too much caution, and we delay relief for those who suffer. Too much courage, and we risk unintended harm. Australia has leaned forward.

The United States, through the U.S. Food and Drug Administration, remains measured.

Perhaps both approaches are necessary. As for me, I will continue to watch, to reflect, and as I have done since 2009, to write.

Because sometimes, the most important developments in life are the ones that challenge what we thought we already knew.

Meanwhile, here's the AI Overview

Based on the FDA’s actions in 2024 and 2025, the journey toward approving MDMA-assisted therapy for PTSD has hit significant regulatory roadblocks, highlighting a strict adherence to traditional pharmaceutical approval standards despite the potential of the therapy.

 

Current Regulatory Status

• FDA Rejection (August 2024): The FDA officially declined to approve MDMA capsules for PTSD treatment, as requested by Lykos Therapeutics, citing that the data submitted was not sufficient to show the treatment was safe and effective.
• Advisory Committee Vote: In June 2024, an FDA advisory panel voted 9-2 against the effectiveness of the treatment and 10-1 that the benefits did not outweigh the risks.
• Requirement for More Data: The FDA has asked for additional research, specifically requiring another randomized controlled trial to confirm the safety and efficacy of the drug. 

Key Concerns from the "FDA Lens"

• Blinding Issues: A major challenge is "unblinding." Because MDMA produces intense psychoactive effects, participants often know if they received the drug or a placebo, which can bias the results.
• Safety Data Limitations: The FDA noted risks such as increased heart rate and blood pressure (cardiovascular issues). Furthermore, they found the clinical laboratory data to be limited, and the potential for abuse was not adequately characterized.
• Therapy Standardization: The FDA noted that the psychotherapy component, which is inseparable from the drug treatment, was not sufficiently standardized, and the exact contribution of the psychotherapy to the positive outcomes was unclear.
• Functional Impairment: The FDA raised concerns regarding patient vulnerability during the session and the potential for abuse of the substance. 

The Path Forward

• Not the End of Research: While considered a major setback by advocates, the decision is viewed as a "reset" for the field to meet rigorous scientific standards rather than a permanent ban on psychedelic medicine.
• Ongoing Studies: Research continues, and the FDA has provided guidance on how to conduct studies to meet their regulatory requirements.
• Focus on Rigor: The FDA emphasizes that for approval, MDMA must meet the same stringent standards for data robustness as any other pharmaceutical drug. 
• Meanwhile My Photos of the Day: Super Blooms in my Patio This Week
• 
  
  
  
  
  
  
  
  
  

The Quiet Danger Among Us - Falling

The Quiet Danger Among Us: Reflections on Falling—and Not Falling—in a Senior Community

When I first moved into THD three years ago, the rhythm of life here felt steady, almost reassuring. In that first year, I recall only a single fall serious enough to require a trip to the emergency room. It was an isolated incident, the kind we acknowledged with concern but not alarm.

Today, the picture has changed.

In just the past three months, four residents have fallen, each incident resulting in emergency care and even short hospital stays. One of the more startling cases involved one of our youngest residents, a man in his early 70s. A fall inside his own apartment left him with a broken tooth and a cut across his forehead. The other three were in their late 80s, a reminder that age, while a factor, does not fully predict vulnerability.

It makes one pause.

A fourfold increase in serious falls over three years is not just a statistic, it is a signal. Something is shifting, whether it be in our bodies, our environment, or perhaps even our habits.

The Fragility We Learn to Live With

Aging brings with it a certain quiet negotiation with gravity. Muscles lose strength, balance becomes less reliable, reflexes slow. What was once an effortless turn or quick step can become a calculated movement.

Falls are not merely accidents; they are often the result of a chain of small changes, reduced flexibility, diminished strength, medications that affect balance, or even something as simple as poor lighting.

And yet, falls are not inevitable.

The Case for Prevention

If there is one lesson these recent events offer, it is that prevention must become part of our daily consciousness.

Flexibility and balance exercises are not luxuries; they are necessities. Gentle stretching, tai chi, or even guided chair exercises can improve coordination and help the body respond more effectively when balance is challenged. Flexibility may not prevent every fall, but it can lessen the severity when one occurs.

Strength training, even in modest forms, helps maintain the muscles that keep us upright. Legs, in particular, are our first line of defense against instability.

Assistive devices, often resisted at first, can be life-saving companions. Canes and walkers are not symbols of decline; they are instruments of independence. In my own case, I have relied on a quad cane since moving here. It has become an extension of my mobility, offering stability and confidence with each step.

Environmental awareness also plays a role. Clear pathways, proper lighting, secure rugs, and well-placed handrails can quietly reduce risk.

A Personal Note of Gratitude

I consider myself fortunate. Despite the passing years and the realities of aging, I have not experienced a hard fall. I attribute this partly to vigilance, partly to the steady support of my quad cane and perhaps, in ways I cannot fully explain, to grace.

I often say a quiet prayer of thanks for that.

Looking Out for One Another

One of the overlooked strengths of a senior community is the collective wisdom and care we can offer each other. A gentle reminder to use a walker, a shared exercise class, or even a conversation about safety can ripple outward in meaningful ways.

We are, in a sense, each other’s safety net.

Closing Thoughts

These recent falls are sobering, but they are also instructive. They remind us that while aging may be inevitable, how we respond to it is not.

Prevention is not about eliminating risk entirely, that would be impossible. It is about reducing vulnerability, maintaining dignity, and preserving as much independence as we can.

And so, we adapt. We stretch. We steady ourselves, sometimes with a cane, sometimes with a helping hand, and always, I hope, with a measure of awareness.

Because in this stage of life, staying upright is more than physical, it is a quiet act of resilience.

Meanwhile, here's the AI Overview

Falling in senior communities is a critical, often hidden danger driven by physical decline, environmental hazards, and the psychological fear of losing independence

. Effective prevention requires a combination of home modifications (grab bars, lighting), exercise, and proactive, personalized care rather than restrictive measures. 

Key Aspects of Falling and Prevention:

• Physical Factors: Lower body weakness, poor mobility, and medication side effects are major contributors to falls, which can lead to severe injuries like hip fractures.
• The "Not Falling" Challenge: Fear of falling, or anxiety about it, can severely limit a senior's mobility and quality of life, often causing them to become more sedentary and increasing risk over time.
• Environmental Hazards: Poorly lit areas, uneven flooring, and lack of grab bars in bathrooms turn daily routines into risks.
• Institutional Solutions: Effective management involves fall audits, staff training, and tailored exercise routines rather than using restraints, which can actually increase risks.
• Psychological and Social Impact: Beyond physical injuries, falling can lead to isolation. It’s important for communities to foster a supportive environment that encourages active living and dignity, combating the isolation that can accompany aging. 

Effective fall reduction strategies focus on empowering seniors to remain active and safe, rather than just treating falls as an inevitable part of aging.

 My Two Quotes of the Day:

“A positive thinker sees the invisible, feels the intangible, and achieves the impossible.”

Anonymous

 

“You can’t stop the waves, but you can learn how to surf.”

John Kabat-Zinn

 

Finally, here are five major news items making the rounds today:

1. A vehicle struck parade-goers in Louisiana, injuring at least 15 people.

2. UCLA won its first women’s NCAA championship, beating South Carolina 79-51.

3. U.S. officials said an airman downed over Iran was recovered after a high-risk rescue effort.

4. Trump said the U.S. could escalate sharply if Iran does not agree to a deal soon.

5. A cruise ship ran aground on a reef in Fiji, forcing passengers to evacuate.

   
   

Mark Higuera and His Piano Music

Photo Credit: Wendee Williamson 

Five Attendees to The Piano Music of Mark Higuera, Easter Sunday, 11-1PM  

This morning,  THD Residents were treated to Mark Higuera Piano Music. Unluckily, there were ony a few listeners because of the time period. Almost all of the Residents are at our Sunday Easter Brunch. I bet if the time was scheduled at 3PM today, the Lobby will be standing room only. I enjoyed Mark rendition of the popular piano music from the classical, braodway and jazz piano pieces. Marsha requested Mark play, My Way. I enjoyed Moon River, The Nearness of You, Unforgettable, Somewhere and other old popular piano music, Macrine used to play during our early married years. Here's a photo of Mark and some AI Information on him. 

Mark Higuera is a 

local pianist and musician performing in the Livermore and Pleasanton area, frequently playing classic melodies for senior living communities. Known for his performances at venues like Sunol Creek Memory Care, he provides live, engaging piano concerts and has performed for events such as Valentine's Day. 

Key Details Regarding Mark Higuera:

• Performance Style: Captivates audiences with "timeless piano classics".
• Local Presence: Active in the Tri-Valley area, specifically noted for performances in Pleasanton and Livermore.
• Venues: Has performed at Sunol Creek Memory Care.
• Online Presence: Shares musical moments on Instagram and maintains personal web content. 

He is recognized by local care communities as a talented pianist who brings joy through music.